Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23477634 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage
Condition: Hemorrhage
Interventions: Drug: Tranexamic acid;   Drug: Sodium Chloride 0.9%

Indicates status has not been verified in more than two years